Emtricitabine + tenofovir

Trade Name: 
Descovy
Manufacturer/Distributor: 
Gilead Sciences Canada
Classification: 
Antiretroviral agent
ATC Class: 
J05AR - antivirals for HIV, combinations
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2016/04/28
Date Marketed in Canada (yyyy/mm/dd): 
2016/06/03
Presentation: 
Tablet: 200 mg emtricitabine + 10 mg tenofovir. DIN: 02454416
Tablet: 200 mg emtricitabine + 25 mg tenofovir. DIN: 02454424
Comments: 
Used in combination with other antiretrovirals (such as non-nucleoside reverse transcriptase inhibitors or protease inhibitors) for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older (and weighing ≥35 kg).